Transcriptional down regulation of stromelysin by tetracycline

Journal of Cellular Biochemistry

Volumn 60, Issue 3, 1996, Pages 341-347

  Jonat, Carsten ^a   Chung, Fu Zon ^a   Baragi, Vijaykumar M ^a  

^a PFIZER INC   (United States)

Author keywords

Antibiotics; Interleukin; Matrix metalloproteinases; Transcriptional regulation

Indexed keywords

STROMELYSIN; TETRACYCLINE;

ARTICLE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME INDUCTION; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

BASE SEQUENCE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; MATRIX METALLOPROTEINASE 3; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEQUENCE DELETION; TETRACYCLINE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0029875811     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960301)60:3<341::AID-JCB6>3.0.CO;2-W     Document Type: Article

References (41)

1. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M (1987): Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49 (6): 729-739
2. Auble DT, Brinckerhoff CE (1991): The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30 (18):4629-4635
3. Baldwin E, Kayalar C (1986): Metalloendoprotease inhibitors that block fusion also prevent biochemical defferentiation in L6 myoblasts. Proc Natl Acad Sci USA 83 (21): 8029-8033
4. Brinckerhoff CE, Sirum-Connolly KL, Karmilowicz MJ, Auble DT (1992): Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts. Matrix Suppl 1: 165-175
5. Brinckerhoff CE (1991): Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis-Rheum 34 (9): 1073-1075
6. Buttice G, Kurkinen M (1993): A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J Biol Chem 268 (10): 7196-7204
7. Buttice G, Quinones S, Kurkinen M (1991): The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res 19 (13):3723-3731
8. Case JP, Lafyatis R, Kumkumian GK, Remmers EF, Wilder RL (1990): IL-1 regulation of transin/stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transduction pathways, an inhibitory, prostaglandin-dependent pathway mediated by cAMP, and a stimulatory, protein kinase C-dependent pathway. J Immunol 145 (11): 3755-3761
9. Ciancio SG (1994): Clinical experiences with tetracyclines in the treatment of periodontal diseases. Ann NY Acad Sci 732: 132-139
10. Conoa W (1993): The matrix metalloproteinase gene family: structure, function, expression, and role in destructive joint disease. Immun Infekt Suppl 1: 20-21
11. DiBattista JA, Martel-Pelletier J, Wosu LO, Sandor T, Antakly T, Pelletier JP (1991). Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes J Clin Endocrinol Metab 72 (2): 316-326
12. Frisch SM, Ruley HE (1987): Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 262 (34): 16300-16304
13. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS (1983): Minocycline reduces gingival collagenolytic activity during diabetes. Preliminaary observations and a proposed new mechanism of action. J Periodontal Res 18 (5): 516-526
14. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS (1987): A nonantibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66 (8): 1310-1314
15. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991): Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2 (3): 297-321
16. German CM, Moffat LF, Howard BH (1982): Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2 (9): 1044-1051
17. Graham FL, van der EBAJ (1973): A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 (2): 456-467
18. Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, McNamara TF (1987): Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 14 (1): 28-32
19. Gross JL, Moscatelli D, Rifkin DB (1983): Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA. 80 (9): 2623-2627
20. Henthorn P, Zervos P, Raducha M, Harris H, Kadesch T (1988): Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. Proc Natl Acad Sci USA 85 (17): 6342-6346
21. Jonat C, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P (1990): Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 (6): 1189-1204
22. Kerr LD, Miller DB, Matrisian LM (1990): TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61 (2): 267-278
23. Kinane DF (1992). Metalloproteinases in the pathogenesis of periodontal diseases. Curr Opin Dent 2: 25-32
24. Krane SM (1994): Clinical importance of metalloproteinases and their inhibitors. Ann NY Acad Sci 732: 1-10
25. Liotta LA, Wewer U, Rao NC, Schiffmann E, Stracke M, Guirguis R, Thorgeirsson U, Muschel R, Sobel M (1988): Biochemical mechanisms of tumor invasion and metastases. Prog Clin Biol Res 256: 3-16
26. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP (1994): Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70 (6): 807-815
27. auviel A, Halcin C, Vasiloudes P, Parks WC, Kurkinen M, Uitto J (1994): Uncoordinate regulation of collagenase, stromelysin. and tissue inhibitor of metalloproteinases genes by prostaglandin E2. selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J Cell Biochem 54 (4): 465-472
28. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53 (4): 288-295
29. McDonnell S, Matrisian LM (1990): Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 9 (4): 305-319
30. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P (1990): Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 9 (13): 4443-4454
31. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J (1992): Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium Br J Rheumatol 31 Suppl 1: 19-26
32. Rashad S, Low F, Revell P, Hemmingway A, Rainsford K, Walker F (1989): Effect of non-steroidal anti-inflammatory drugs on course of osteoarthritis. Lancet 2 (8672): 1149
33. Rifkin BR, Vernillo AT, Golub LM (1993): Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 64 Suppl 8:819-827
34. Sirum-Connolly K, Brinckerhoff CE (1991): Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1. Nucleic Acids Res 19 (2): 335-341
35. Takahashi S, Sato T, Ito A, Ojima Y, Hosono T, Nagase H, Mori Y (1993): Involvement of protein kinase C in the interleukin 1 alpha-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts. Biochim Biophys Acta 1220 (1): 57-65
36. Thomas PS (1980): Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77 (9): 5201-5205
37. Uitto VJ, Firth JD, Nip L, Golub LM (1994): Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci 732: 140-151
38. Wasylyk C, Gutman A, Nicholson R, Wasylyk B (1991): The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.EMBO J 10 (5): 1127-1134
39. Webster GF, Toso SM, Hegemann L (1994): Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch Dermatol 130 (6): 748-752
40. Woessner JF (1991): Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154
41. Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR (1994): The nonantimicrobial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol. 111-118